We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · October 26, 2021

ECTRIMS 2021: COVID-19 Seroconversion Rates are Lower in Patients With MS Who Have Received Certain Disease-Modifying Therapies

Some drugs are linked to failure to develop a post-vaccination humoral response.

PracticeUpdate Editorial Team


Further Reading